Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,141.23
(
0.07%
)
US TECH 100
26,421.20
(
-0.16%
)
Dow Jones
49,233.45
(
0.76%
)
Brent Oil
109.47
(
-2.59%
)
Bitcoin
76,230.61
(
0.60%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Johnny_C

Send PM Follow Ignore
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Johnny_C

Re: DewDiligence post# 217307

Thursday, 02/15/2018 9:56:29 AM

Thursday, February 15, 2018 9:56:29 AM

Post# of 257470
Sure, and they still think the drug has blockbuster potential. But BMY represents massive sales, Eliqius growth and their oncology lineup...They also have one state of the art new Biologic facility recently opened in Boston and they are constructing another one in Ireland.

Biolgics will create the longer streams of revenue post patent expiry.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today